| 000 | 00955 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513175346.0 | ||
| 264 | 0 | _c19990507 | |
| 008 | 199905s 0 0 fre d | ||
| 022 | _a0040-5957 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJean-Pastor, M J | |
| 245 | 0 | 0 |
_a[Evaluation of the impact of a letter of information about metoclopramide]. _h[electronic resource] |
| 260 |
_bTherapie _c |
||
| 300 |
_a63-4 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aDopamine Antagonists _xadverse effects |
| 650 | 0 | 4 |
_aDrug Therapy _xstandards |
| 650 | 0 | 4 | _aDrug-Related Side Effects and Adverse Reactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMetoclopramide _xadverse effects |
| 650 | 0 | 4 | _aPhysicians |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 700 | 1 | _aRodor, F | |
| 700 | 1 | _aNguyen, N | |
| 700 | 1 | _aGambini, D | |
| 700 | 1 | _aLocatelli, C | |
| 700 | 1 | _aObedia, E | |
| 773 | 0 |
_tTherapie _gvol. 54 _gno. 1 _gp. 63-4 |
|
| 999 |
_c10175623 _d10175623 |
||